SCHEMBL20669482

SCHEMBL20669482

CC(C)(CC(C)(C)C(C)(C)C)NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanoctine SCHEMBL5909699 0.81 POLB (0.38)
SCHEMBL22365664 0.81
Guanoctine SCHEMBL121121 0.79 POLB (0.37)
SCHEMBL27115012 0.79
SCHEMBL18792696 0.77 POLB (0.32)
SCHEMBL25015357 0.77
SCHEMBL21350057 0.77
SCHEMBL22511428 0.76
SCHEMBL18520505 0.76
SCHEMBL19636411 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022192162-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE FOX CHASE CHEMICAL DIVERSITY CENTER, INC. (US) 2022-09-15 WO disclosed
US-20200318195-A1 Bivalent Nucleic Acid Ligands and Uses Therefor CARNEGIE MELLON UNIVERSITY 2020-10-08 US disclosed
US-20200308220-A1 AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME CLINICAL RESEARCH INSTITUTE OF MONTREAL (CA) 2020-10-01 US disclosed
US-20190276494-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES STEALTH BIOTHERAPEUTICS INC. 2019-09-12 US disclosed
US-20190022165-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PULMONARY ARTERIAL HYPERTENSION STEALTH BIOTHERAPEUTICS CORP (MC) 2019-01-24 US disclosed
US-20190022167-A1 METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY STEALTH BIOTHERAPEUTICS INC. 2019-01-24 US disclosed